High levels of vitamin C kill certain kinds of colorectal cancers in cell cultures and mice, according to a new study. The findings suggest that scientists could one day harness vitamin C to develop targeted treatments.
A team of scientists has made a discovery that suggests cancer cells benefit more from antioxidants than do normal cells, raising concerns about the use of dietary antioxidants by patients with cancer.
Dietary supplementation with vitamin D and/or calcium after removal of precancerous colorectal adenomas (polyps) does not reduce risk of developing future adenomas.
No reduction in risk of distant metastasis, cancer-related deaths, radiation-linked adverse effects were connected to the use of men's health supplements (MHSs).
The addition of omega-3 fatty acids to antitumor medications may improve treatment response and improve quality of life for cancer patients.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Coping With Lymphedema: A Patient Guide (Fact Sheet)
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|